U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C39H62O14
Molecular Weight 754.9012
Optical Activity UNSPECIFIED
Defined Stereocenters 22 / 22
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PAMAQUESIDE

SMILES

C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5C[C@H](CC[C@]5(C)[C@H]4C(=O)C[C@]23C)O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)O[C@]18CC[C@@H](C)CO8

InChI

InChIKey=VWMZIGBYZQUQOA-QEEMJVPDSA-N
InChI=1S/C39H62O14/c1-17-7-10-39(48-16-17)18(2)27-24(53-39)12-22-21-6-5-19-11-20(8-9-37(19,3)28(21)23(42)13-38(22,27)4)49-35-33(47)31(45)34(26(15-41)51-35)52-36-32(46)30(44)29(43)25(14-40)50-36/h17-22,24-36,40-41,43-47H,5-16H2,1-4H3/t17-,18+,19+,20+,21+,22+,24+,25-,26-,27+,28-,29-,30+,31-,32-,33-,34-,35-,36+,37+,38+,39-/m1/s1

HIDE SMILES / InChI

Molecular Formula C39H62O14
Molecular Weight 754.9012
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 22 / 22
E/Z Centers 0
Optical Activity UNSPECIFIED

Pamaqueside, an 11-ketotigogenin cellobioside was developed as a cholesterol absorption inhibitor for the treatment of hypercholesterolemia. This drug participated in phase III clinical trial; however, information about the further development of this drug is not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
Pamaqueside. CP 148623.
2002
Metabolism of pamaqueside, a cholesterol absorption inhibitor, in Long-Evans rat: effect of bile duct cannulation on absorption.
1999-10
11-Ketotigogenin cellobioside (pamaqueside): a potent cholesterol absorption inhibitor in the hamster.
1996-05-10
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:01:15 GMT 2025
Edited
by admin
on Mon Mar 31 18:01:15 GMT 2025
Record UNII
L1Y3WKM9WU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CP-148,623
Preferred Name English
PAMAQUESIDE
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
pamaqueside [INN]
Common Name English
CP-148623
Code English
SPIROSTAN-11-ONE, 3-((4-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-, (3.BETA.,5.ALPHA.,25R)-
Common Name English
Pamaqueside [WHO-DD]
Common Name English
PAMAQUESIDE [USAN]
Common Name English
11-OXO-(25R)-5.ALPHA.-SPIROSTAN-3.BETA.-YL 4-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSIDE
Common Name English
Code System Code Type Description
INN
7440
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
MESH
C099629
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
FDA UNII
L1Y3WKM9WU
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
EVMPD
SUB09594MIG
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
CAS
150332-35-7
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
SMS_ID
100000082782
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
USAN
GG-90
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
PUBCHEM
9918516
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
NCI_THESAURUS
C170284
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
EPA CompTox
DTXSID001350961
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
ChEMBL
CHEMBL505268
Created by admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
PRIMARY
Related Record Type Details
TARGET->INHIBITOR OF ABSORPTION
Related Record Type Details
ACTIVE MOIETY